Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

SELL
$0.59 - $1.04 $649 - $1,144
-1,100 Reduced 3.63%
29,190 $20,000
Q4 2022

Jan 13, 2023

BUY
$0.66 - $259.46 $66 - $25,945
100 Added 0.33%
30,290 $0
Q2 2022

Jul 12, 2022

BUY
$0.51 - $0.93 $510 - $930
1,000 Added 3.43%
30,190 $20,000
Q1 2022

Apr 21, 2022

BUY
$0.84 - $1.71 $12,600 - $25,650
15,000 Added 105.71%
29,190 $24,000
Q4 2021

Feb 11, 2022

BUY
$1.59 - $2.38 $2,865 - $4,288
1,802 Added 14.55%
14,190 $23,000
Q3 2021

Nov 15, 2021

BUY
$1.69 - $2.89 $1,711 - $2,927
1,013 Added 8.91%
12,388 $30,000
Q2 2021

Aug 16, 2021

BUY
$2.64 - $6.32 $30,030 - $71,890
11,375 New
11,375 $30,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0

About SEELOS THERAPEUTICS, INC.


  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $117M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track First Heartland Consultants, Inc. Portfolio

Follow First Heartland Consultants, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Heartland Consultants, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Heartland Consultants, Inc. with notifications on news.